01:29

Patients with cancer face high prescription drug costs that many Canadians are unaware of

00:26

Arthur Fabbro, Jr. - Drug benefits are an increasing burden to employers

00:34

The current inequity in drug coverage leaves many Canadians helpless

00:35

Improving prescribing practices in Canada would benefit patient health and lower costs

00:32

The current inequity in drug coverage leaves many Canadians helpless

01:37

Anna Reid - The consequences of inadequate access to medication

00:34

Marc-André Gagnon - The case for universal public pharmacare

00:23

Arthur Fabbro, Jr. - Drug benefits are an increasing burden to employers

01:55

Marc-André Gagnon - Canada's current drug coverage system is unsustainable

00:33

Improving prescribing practices in Canada would benefit patient health and lower costs

01:42

Patients in need face high costs for prescription drugs in Canada's health care system

02:06

Barbara Mintzes - Quality use of medicines is a key goal of pharmacare reform

00:48

Steven Lewis - Pharmacare is the next frontier in the Canadian health system

00:22

Steven Lewis - A substantial number of Canadians to not have adequate drug coverage

01:58

Steven Lewis - Debunking arguments against universal pharmacare in Canada

01:41

Steven Lewis - Pharmacare reform is a win-win-win for Canadians

01:56

David Henry - Creating a pharmacare policy that meets Canadians' needs

01:45

Anna Reid - Integrating pharmaceuticals into the health care system

02:03

Marc-André Gagnon - The case for universal public pharmacare

02:14

Barbara Mintzes - Quality use of medicines is a key goal of pharmacare reform

01:38

Michael Law - Cost is a barrier to medicine access for Canadians

01:25

Marie-Claude Prémont - Canada should learn from Quebec pharmacare

01:33

Arthur Fabbro, Jr. - Drug benefits are an increasing burden to employers

01:24

Colleen Fuller - Supporting informed consumer choices

00:22

What is Pharmacare 2020?

15:16

Steven Lewis - The winners and losers of pharmacare reform

13:42

Steve Morgan - Marshalling the evidence for pharmacare reform in Canada

03:33

Q&A - Pharmacare 2020: What could work? Will we ever get there?

06:21

Michael McBane (CHC) - A Vision for Pharmacare

05:42

Jordan Bateman (CTF) - A Vision for Pharmacare

04:51

Anna Reid (CMA) - A Vision for Pharmacare

09:00

Mark Collison (HSF) - A Vision for Pharmacare

06:11

Dan Clow (Rx&D) - A Vision for Pharmacare

16:47

Q&A - Visions for Pharmacare

12:20

Arthur Fabbro - Employer perspective on private drug benefits in Canada

11:22

Stephen Frank - The role of private insurance in Canadian pharmacare

11:23

Marie-Claude Prémont - Overview of Quebec's pharmacare system

13:11

Q&A - Current and future roles for private insurance for prescription drugs in Canada

12:01

Michael Law - Achieving lower generic prices in Canada

12:45

Jim Keon - Manufacturer perspective on generic drug pricing in Canada

08:51

Jody Shkrobot - Impact of generic pricing reform on Canadian pharmacies

12:19

Q&A - Generic drug pricing and availability

12:05

Diane McArthur - Product listing agreements for patented medicines

09:44

Michelle Boudreau - The role of the Patented Medicines and Prices Review Board

12:33

Claudia Neuber - Manufacturer perspective on patented drug pricing in Canada

12:53

Q&A - Patented Drug Coverage and Pricing

13:07

Marc-André Gagnon - Overview of Canada's pharmacare system

12:38

Barbara Walman - Overview of BC's income-based pharmacare program

12:48

Colleen Fuller - The role of unions and employers in the pharmacare debate

11:50

Q&A - Pharmacare in Canada today

01:47

Patients in need face high costs for prescription drugs in Canada's health care system

01:05

Hon. Roy Romanow on national pharmacare and engagement needed to make it happen

01:32

Patients with cancer face high prescription drug costs that many Canadians are unaware of

01:35

Patients often face barriers to accessing the medicines their doctors prescribe

01:35

Patients in need may not qualify for private insurance

01:40

Patient costs can be a barrier to accessing needed medicines

01:02

Patients forced to be the managers of prescription drug costs

01:23

Patient concerns about value for money spent on prescription drugs

01:55

Patients fall through the cracks of Canadian pharmacare

00:58

Welcome to Pharmacare 2020